
1. virol j. 2009 may 12;6:54. doi: 10.1186/1743-422x-6-54.

sales oseltamivir norway prior emergence oseltamivir resistant
influenza a(h1n1) viruses 2007-08.

hauge sh(1), blix hs, borgen k, hungnes o, dudman sg, aavitsland p.

author information: 
(1)department infectious disease epidemiology, norwegian institute public
health, oslo, norway. siri.helene.hauge@fhi.no

background: unprecedented high proportion oseltamivir resistant influenza
a(h1n1) viruses emerged 2007-08 influenza season. norway, two thirds of
all tested a(h1n1) viruses resistant antiviral drug. order see 
if emergence could explained drug induced selection pressure, we
analysed data sales oseltamivir norway years 2002-07.
methods: used data two sources; norwegian drug wholesales statistics 
database norwegian prescription database (norpd), years
2002-2007. calculated courses sold oseltamivir (tamiflu) per 1000
inhabitants per year.
results: data showed that, except years 2005 2006, sales of
oseltamivir low norway; courses sold per 1000 inhabitants varied 
0.17-1.64. higher sales 2005 2006 believe caused private
stockpiling fear pandemic, represent actual usage.
conclusion: drug induced selection pressure probably cause the
emergence oseltamivir resistant influenza a(h1n1) viruses 2007-08 in
norway.

doi: 10.1186/1743-422x-6-54 
pmcid: pmc2685787
pmid: 19435505  [indexed medline]

